My takeaways:
1. EMD AML is now R/R AML (in combo with Decatabine + Venetoclax)
2. Cardio Protect (RC220 safety / pharmacology works to be finalised pre-trial), something that has been aired before.
3. FTO (looks more like a Diagnostic / CDx program for validation - no actual trial for solid tumors planned).
Have to absorb and do some numbers. Good to get everyone else's thoughts.
Ann: Race Strategic Update August 2023, page-14
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.87 |
Change
0.100(5.67%) |
Mkt cap ! $312.5M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.88 | $1.78 | $310.9K | 168.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 535 | $1.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 2228 | 1 |
View Market Depth
| Last trade - 11.55am 11/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |